Linking Chiral Clusters with Molybdate Building Blocks: From Homochiral Helical Supramolecular Arrays to Coordination Helices

The synthesis of four new oxo‐centered Fe clusters ( 1 a – c , 2 ) of the form [Fe^III₃(μ₃‐O)(CH₂=CHCOO)₆] with acrylate as the bridging ligand gives rise to potentially intrinsically chiral oxo‐centered {M₃} trimers that show a tendency to spontaneously resolve upon crystallization. For instance, 1 a , [Fe^III₃(μ₃‐O)(CH₂=CHCOO)₆‐(H₂O)₃]⁺, crystallizes in the chiral space group P3₁ as a chloride salt. Crystallization of 1 b , [Fe₃(μ₃‐O)(C₂H₃CO₂)₆(H₂O)₃]NO₃?4.5H₂O, from aqueous solution followed by recrystallization from acetonitrile also gives rise to spontaneous resolution to yield the homochiral salt [Fe₃(μ₃‐O)(C₂H₃CO₂)₆‐(H₂O)₃]NO₃?CH₃CN of 1 c (space group P2₁2₁2₁). Furthermore, the reaction of 1 a with hexamolybdate in acetonitrile gives the helical coordination polymer {[(Fe₃(μ₃‐O)L₆(H₂O))(MoO₄)‐(Fe₃(μ₃‐O)L₆(H₂O)₂)]?2CH₃CN?H₂O}_∞ 2 (L: H₂C?CHCOO), which crystallizes in the space group P2₁. The nature of the ligand geometry allows the formation of atropisomers in both the discrete ( 1 a – c ) and linked {Fe₃} clusters ( 2 ), which is described along with a magnetic analysis of 1 a and 2 .     

Er~(3 ),Ho~(3 )和Tm~(3 )在硫氧化钆中的余辉发光

非放射性长余辉磷光粉作为美化和清洁光源在发光陶瓷、交通安全标志、紧急突发事件的照明设施、工艺美术涂料等众多领域得到越来越广泛的应用,引起人们的重视.到目前为止,文献报道的稀土长余辉磷光体的激活离子主要有铕离子(Eu3+和Eu2+[1-4]、三价铈离子(Ce3+)[5]、三价铽离子(Tb3+)[6]、三价镨离子(Pr3+)[7]、三价钐离子(Sm3+)[8].Ho3+,Er3+,Tm3+等稀土离子作为红外上转换发光材料的激活离子[9～12],而关于它们的长余辉发光的报道极少.最近,雷炳富等在Tm3+离子[13]激活的硫氧化钇体系中发现了长余辉发光.在此,我们通过高温固相法合成了Er3+,Ho3+和Tm3+掺杂的硫氧化钆长余辉磷光粉,观察到该体系中迄今未见文献报道的Er3+,Ho3+和Tm3+离子的长余辉发光.     

Supramolecular structures of macromolecules containing bipyridine–copper(I) complexes as revealed from transmission electron microscopy studies

Transmission electron microscopy (TEM) studies on bipyridine (bpy) containing block copolymer systems showed the formation of nanoscopic polymer–ion complexes through complexation with copper(I) ions which segregated to highly ordered columnar domains of mesoscopic dimensions. The domains, i.e. stacks of [(bpy)₂Cu(I)] complex moieties could be visualized by complementary TEM techniques. First, electron energy loss spectra (EELS) showed the absorption edges of copper and nitrogen, which are specific for the bipyridine copper complexes. The element spectroscopic imaging (ESI) technique allowed the imaging of the net copper and net nitrogen distribution, and the coinciding pictures exhibited a microphase separated system in the case of a 3-block copolymer with complexed end segments. High resolution elastic bright field images showed interference lines with a line to line distance of about 8 A which could be related to the Cu–Cu distance in staggered Cu(I)–bipyridine complexes. Received: 6 August 1997 Accepted: 28 April 1998     

用两种方法合成长余辉发光玻璃的对比研究

在还原性气氛下高温固相反应法（一步法）合成了长余辉发光玻璃GA；用SrAl2O4:Eu,Dy荧光粉（SAED）与玻璃粉混合高温熔融（二步法）合成了长余辉发光玻璃GB和GC，通过XRD，发光光谱和磷光衰减曲线对样品进行了表征，荧光粉SAED和玻璃GA，GB，GC的发射峰值依次是525，493。462，516nm，发光强度和余辉时间都是SAED＞GC＞GB＞GA，玻璃的发射光谱峰随玻璃组成不同发生位移，两种发生合成的夜光玻璃发光性质存在明显的差异，同一合成方法下，玻璃基料决定着玻璃网络结构，同时也影响着夜光玻璃的发光性质。     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

Hydrothermal synthesis, crystal structures and luminescent properties of two new Ln(III)–succinate (Ln=Eu, Tb) complexes exhibiting three dimensional networks

Two new coordination polymers, [Eu₂(L)₃(H₂O)₂]_n 1 and {[Tb₂(L)₃(H₂O)₂]·H₂O}_n 2, (H₂L=succinic acid) have been synthesized by the reaction of H₂L with nitrate salts of Eu(III) or Tb(III) under hydrothermal conditions. The X-ray diffraction analysis reveals that the two complexes are constructed by L bridging the chains of edge-sharing EuO₈(H₂O) or TbO₈(H₂O) polyhedra to form 3D network structure. 1 and 2 possess different topological structures due to the difference in the conformations of L. The solid photoluminescence of 1 and 2 was also investigated in room temperature.     

Synthesis and crystal structures of heterobimetallic Fe-Cd,Fe-Zn,and Fe-In complexes containing hemilabile phosphorus/oxygen and silicon/oxygen bridging ligands

The reactions of K[Fe{Si(OMe)₃}(CO)₃(PY)][PY=Ph₂PCH₂C(O)Ph, Ph₂PCH₂C(O)[(-C₅H₄)FeCp] (Cp=⁵-C₅H₅), Ph₂P(CH₂)₂CN] with CdCl₂·2.5H₂O, ZnX ₂ (X=Cl, I) or InCl₃ afforded Fe-Cd-Fe or Fe-M(-X)₂ M-Fe (M=Cd, Zn, In;X=Cl, I) and Fe-InCl₂ complexes. Some of them contain an unusual and labile -²-SiO alkoxysilyl bridge which may be associated with a bridging mode for the ketophosphine ligand (first such example structurally established), thus providing original results in bimetallic chemistry on the intramolecular coordination of oxygendonor functions ofchemically different hemilabile ligands firmly attached to a neighboring metal center. The structures of the trinuclear complex (3), of the chlorobenzene solvate of the tetranuclear complex (4a·C₆H₅Cl) and of [mer-(OC)₃{(EtO)₃Si} (4e) have been determined by X-ray diffraction. Crystals of 3 are orthorhombic, space groupPbcn, witha=19.010(4),b=11.766(5),c=26.998(7)Å, andZ=4. Crystals of4a·C₆H₅Cl are monoclinic, space groupC2/c witha=22.455(3),b=17.680(2),c=16.627(4)Å, =90.80(4)°, andZ=4. Crystals of4e are monoclinic, space groupC2/c witha=25.392(5),b=18.554(6),c=16.28(1)Å, =120.73(3)°, andZ=4. The structures were solved using direct methods and Fourier difference techniques and refined by blocked full-matrix least squares toR=0.035 (R _w =0.049) for 2719 observed reflections, toR=0.042 (R _w =0.056) for 3082 observed reflections, and toR=0.057 (R _w =0.075) for 1850 observed reflections for3, 4a·C₆H₅Cl and4e, respectively. The Fe-Zn complexes (9a), (9b) and (9c) were prepared and characterized by spectroscopic methods.Part 21 in the Series: Complexes with Functional Phosphines. Part 20: P. Braunstein, S. Coco Cea, A. DeCian, and J. Fischer (1992).Inorg. Chem. 31, 4203.     

10,12—双炔廿三酸盐的LB膜特性研究

本文合成了10,12-双炔廿三酸,并用其在Si、SiO_2、CaF_2等基片上沉积了LB膜,结果表明,10,12-双炔廿三酸的镉盐成膜更稳定。这种LB膜在紫外光辐照下很快聚合,聚合前后的紫外-可见吸收光谱发生规律性的变化,并保持层状结构,等同周期稍变。通过红外吸收的二向色性分析,确定了该分子的取向。     

Coordination modes of 2-hydroxynicotinic acid in second- and third-row transition metal complexes

The new Pd(II), Pt(II), Re(V), Mo(VI) and W(VI) complexes of 2-hydroxynicotinic acid (H₂nicO), trans-[PdCl(HnicO)(PPh₃)₂]·0.75CH₃CN (1), K[PdCl(HnicO)₂]·H₂O (2), [Pd(HnicO)₂(bipy)] (3), cis-[PtCl(HnicO)(PPh₃)₂]·0.75CH₃OH·0.5H₂O (4), [PtCl(HnicO)(bipy)] (5), cis-[ReOI₂(HnicO)(PPh₃)] (6), Na₂[Mo₂O₆(HnicO)₂]·5H₂O (7), Na₂[Mo₄O₁₂(HnicO)₂]·2H₂O (8) and Na₂[W₂O₆(HnicO)₂]·5H₂O (9) have been prepared. The crystal structures of 1 and 4, were determined by X-ray diffraction and show the HnicO⁻ ligand coordinated to palladium or platinum through the nitrogen atom only. Infrared, Raman, ¹H and ¹³C{¹H} NMR spectroscopic data for the complexes are presented and are in agreement with the crystallographic results.